30
Participants
Start Date
April 30, 2006
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Olanzapine
16-week open trial of olanzapine. The patients were started on a dose of 15 mg/d by mouth, which could be adjusted to as low as 10 mg/d or as high as 40 mg/d, based on clinical response. The trial began while they were hospitalized and continued after discharge.
Unitat Hospitalitzacio - Servei de Psiquiatria G096, Hospital Clinic C/Villarroel, 170, Barcelona
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH